Bayer AG
UkraineAll drugs from this manufacturer
-
The drug is used to treat genital infections (vaginitis) caused by fungi (usually of the Candida genus), as well as bacterial complications sensitive to clotrimazole.
Dosage form: tablets, vaginal
Active substance Dosage clotrimazole 100 mg ATC: G01AF02
-
The drug is used to treat genital infections (vaginitis) caused by fungi (usually of the Candida genus), as well as bacterial complications if they are sensitive to clotrimazole.
Dosage form: tablets, vaginal
Active substance Dosage clotrimazole 200 mg ATC: G01AF02
-
The drug is used to treat genital infections (vaginitis) caused by fungi (usually of the Candida genus), as well as concomitant bacterial infections sensitive to clotrimazole.
Dosage form: tablets, vaginal
Active substance Dosage clotrimazole 500 mg ATC: G01AF02
-
The drug is intended for the treatment of adult patients with chronic kidney disease (with albuminuria) associated with type 2 diabetes mellitus.
Dosage form: tablets, film-coated
Active substance Dosage finerenone 10 mg ATC: C03DA05
-
The drug is intended for the treatment of adult patients with chronic kidney disease (with albuminuria) associated with type 2 diabetes mellitus.
Dosage form: tablets, film-coated
Active substance Dosage finerenone 20 mg ATC: C03DA05
-
The drug is used to improve image contrast during MRI of the brain and spinal cord, liver, or kidneys, or during magnetic resonance angiography (MRA). It helps the physician better visualize damage and distinguish healthy tissues from pathological ones.
Dosage form: solution for injection
Active substance Dosage gadobutrol 604.72 mg/ml ATC: V08CA09
-
The drug is used as a contraceptive for three years.
Dosage form: intrauterine system
Active substance Dosage levonorgestrel 13.5 mg ATC: G02BA03
-
It is used for replacement therapy of hypogonadism in men if testosterone deficiency is clinically confirmed and supported by test results.
Dosage form: solution for injection
Active substance Dosage testosterone undecanoate 250 mg/ml ATC: G03BA03
-
The drug is used to detect focal liver lesions and obtain additional data regarding their characteristics during magnetic resonance imaging (MRI).
Dosage form: solution for injection
Active substance Dosage gadoteric acid 0.25 mmol/mL ATC: V08CA10
-
The drug is indicated for the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who have stabilized after a recent decompensation of heart failure that required intravenous therapy.
Dosage form: tablets, film-coated
Active substance Dosage vericiguat 2.5 mg ATC: C01DX22
-
The drug is indicated for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction who have stabilized after a recent exacerbation requiring intravenous therapy.
Dosage form: tablets, film-coated
Active substance Dosage vericiguat 5 mg ATC: C01DX22
-
The drug is indicated for the treatment of adults with symptomatic chronic heart failure with reduced ejection fraction who have stabilized after a recent exacerbation of the disease that required intravenous therapy.
Dosage form: tablets, film-coated
Active substance Dosage vericiguat 10 mg ATC: C01DX22